Celgene Corp (NASDAQ:CELG)

113.47
Delayed Data
As of Apr 17
 -2.89 / -2.48%
Today’s Change
68.38
Today|||52-Week Range
129.06
+1.44%
Year-to-Date

Today’s Trading

Previous close116.36
Today’s open115.01
Day’s range113.10 - 115.61
Volume6,409,704
Average volume (3 months)5,460,433
Market cap$90.8B
Dividend yield--
Data as of 4:14pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)+41.84%
Earnings growth (this year)+29.83%
Earnings growth (next 5 years)+23.49%
Revenue growth (last year)+17.89%
P/E ratio47.4
Price/Sales11.75
Price/Book13.92

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca-0.71-0.99%
ABBVAbbVie-0.30-0.48%
LLYEli Lilly and Co-1.02-1.39%
BMYBristol-Myers Squibb+1.67+2.62%
Data as of 4:07pm ET, 04/17/2015

Financials

Next reporting dateApril 30, 2015
EPS forecast (this quarter)$1.06
Annual revenue (last year)$7.6B
Annual profit (last year)$2.0B
Net profit margin26.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert J. Hugin
President &
Chief Operating Officer
Mark J. Alles
Corporate headquarters
Summit, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers